These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11684628)

  • 1. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure.
    Rössig L; Hoffmann J; Hugel B; Mallat Z; Haase A; Freyssinet JM; Tedgui A; Aicher A; Zeiher AM; Dimmeler S
    Circulation; 2001 Oct; 104(18):2182-7. PubMed ID: 11684628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol.
    Rössig L; Haendeler J; Mallat Z; Hugel B; Freyssinet JM; Tedgui A; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2000 Dec; 36(7):2081-9. PubMed ID: 11127444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy.
    Ellis GR; Anderson RA; Lang D; Blackman DJ; Morris RH; Morris-Thurgood J; McDowell IF; Jackson SK; Lewis MJ; Frenneaux MP
    J Am Coll Cardiol; 2000 Nov; 36(5):1474-82. PubMed ID: 11079645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
    Tomiyama H; Watanabe G; Yoshida H; Doba N; Yamashina A
    Am Heart J; 2003 Jan; 145(1):E2. PubMed ID: 12514674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure.
    Ellis GR; Anderson RA; Chirkov YY; Morris-Thurgood J; Jackson SK; Lewis MJ; Horowitz JD; Frenneaux MP
    J Cardiovasc Pharmacol; 2001 May; 37(5):564-70. PubMed ID: 11336107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure.
    Hornig B; Arakawa N; Kohler C; Drexler H
    Circulation; 1998 Feb; 97(4):363-8. PubMed ID: 9468210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
    Chin BS; Langford NJ; Nuttall SL; Gibbs CR; Blann AD; Lip GY
    Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure.
    Nightingale AK; Blackman DJ; Field R; Glover NJ; Pegge N; Mumford C; Schmitt M; Ellis GR; Morris-Thurgood JA; Frenneaux MP
    Clin Sci (Lond); 2003 May; 104(5):529-35. PubMed ID: 12549975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure.
    Rumalla VK; Calvano SE; Spotnitz AJ; Krause TJ; Hilkert RJ; Lin E; Lowry SF
    Ann Surg; 2002 Aug; 236(2):254-60. PubMed ID: 12170032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
    Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase.
    Landmesser U; Spiekermann S; Dikalov S; Tatge H; Wilke R; Kohler C; Harrison DG; Hornig B; Drexler H
    Circulation; 2002 Dec; 106(24):3073-8. PubMed ID: 12473554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.
    Erbs S; Beck EB; Linke A; Adams V; Gielen S; Kränkel N; Möbius-Winkler S; Höllriegel R; Thiele H; Hambrecht R; Schuler G
    Int J Cardiol; 2011 Jan; 146(1):56-63. PubMed ID: 20236716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease.
    Ito K; Akita H; Kanazawa K; Yamada S; Terashima M; Matsuda Y; Yokoyama M
    Am J Cardiol; 1998 Sep; 82(6):762-7. PubMed ID: 9761087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
    George J; Carr E; Davies J; Belch JJ; Struthers A
    Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress.
    Ellis GR; Nightingale AK; Blackman DJ; Anderson RA; Mumford C; Timmins G; Lang D; Jackson SK; Penney MD; Lewis MJ; Frenneaux MP; Morris-Thurgood J
    Eur J Heart Fail; 2002 Mar; 4(2):193-9. PubMed ID: 11959049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.